Why Your Pre-Bed HGH Injection Is Built For The Wrong Body

Your liver does not care how much growth hormone is in your blood. It cares whether the right signals are present at the same time, and that distinction is why timing a growth hormone injection poorly does not just reduce your results but actively works against the physiology you are trying to exploit.

Start with the full chain so the detail makes sense later.

Growth hormone leaves your pituitary gland in pulses, travels through the blood, and arrives at your liver where it triggers the production of something called IGF-1, which is insulin-like growth factor 1, the actual signaling molecule responsible for most of the muscle repair, protein synthesis, and tissue growth people associate with growth hormone itself. Growth hormone is the signal. IGF-1 is the worker. Almost everything downstream, the anabolism, the recovery, the body composition changes, comes from IGF-1, not from growth hormone directly.

So the question of when to inject is really a question of when your liver converts growth hormone into IGF-1 most efficiently. And the answer to that question depends on one more hormone: insulin.

Your liver converts growth hormone to IGF-1 most readily when insulin is present. Not when insulin is high, not when you are in a postprandial spike, but when insulin is present in a way that is rising or active. The growth hormone and the insulin need to overlap in time at the liver. When they do, conversion is efficient. When they do not, growth hormone circulates without producing much IGF-1, and while it is circulating it is doing something else you probably do not want, which is pushing back against insulin at the liver and in peripheral tissue.

That counter-regulatory effect is the mechanism behind the problem with pre-bed injections.

Subcutaneous growth hormone does not absorb instantly. After a subcutaneous injection, plasma growth hormone levels peak roughly four hours later. That is not a guess, that comes from pharmacokinetic data in healthy men where subcutaneous injections produced a gradual absorption curve with peak concentrations arriving around the four-hour mark. So if you inject at ten at night, your exogenous peak arrives at approximately two in the morning.

Here is the collision. Your body is already producing a large pulse of growth hormone during the early part of deep sleep, typically in the first few hours after you fall asleep. Research from Van Cauter and colleagues tracking 24-hour growth hormone secretion patterns showed that the sleep-associated pulse accounts for roughly 70 percent of daily endogenous growth hormone output. That pulse happens on its own every night without any injection.

When you inject at night and your exogenous peak lands at two in the morning on top of an endogenous pulse that is already active, you are not amplifying the pulse in any useful way because your liver can only convert so much at once, and there is no insulin present in the middle of the night to support that conversion anyway. You are fasted and sleeping. What you are actually doing is flooding your system with growth hormone during a window when conversion is low and the anti-insulin effect is high.

Growth hormone suppresses hepatic insulin sensitivity. That is the mechanism behind something called the dawn phenomenon, which is the rise in fasting blood glucose that happens in the early morning hours in response to nocturnal growth hormone secretion. Research in type 1 diabetic patients showed that nocturnal growth hormone spikes directly decrease hepatic and extrahepatic sensitivity to insulin in the absence of any change in insulin levels themselves, which is what drives fasting glucose up by morning. Adding exogenous growth hormone on top of your natural nighttime pulse amplifies exactly that effect, which is why people running pre-bed protocols often wake up with elevated fasting glucose and a groggy, inflamed feeling they cannot fully explain.

The morning protocol works because it reverses the timing relationship.

When you inject fasted in the morning, growth hormone begins climbing as you wake up. You then eat a meal 30 to 60 minutes later. That meal produces an insulin response. The insulin response arrives at your liver while growth hormone is still rising and active. The two signals overlap. Conversion to IGF-1 is efficient. You get the downstream anabolic effects you actually want, and you are not stacking on top of your natural nighttime pulse so that pulse continues to operate on its own the way it was going to anyway.

Now here is where the 1990 study matters and also where it has been misread.

Jorgensen and colleagues published a trial comparing evening versus morning injections in patients who were growth hormone deficient. The result was that 24-hour IGF-1 levels came out essentially the same between the two timing conditions. That result got interpreted as proof that timing does not matter, and for a while pre-bed injections became the accepted protocol partly on the basis that if there is no difference you might as well pin at night.

But the sample was growth hormone deficient patients. Patients whose pituitaries had stopped functioning. They had no endogenous nighttime pulse to protect or compete with. The logic of avoiding nighttime stacking does not apply to someone who is not producing any growth hormone naturally. For someone with intact pituitary function, the 1990 study was never a valid comparison because it was studying a fundamentally different physiological situation.

At doses of four international units or more, splitting the dose is the practical approach because a single morning injection may not sustain elevated IGF-1 levels through the full day. The common approach is to split between morning fasted and late afternoon, which keeps the liver producing IGF-1 through the back half of the day while still leaving the nighttime window entirely clear for endogenous pulsing.

The larger point is this: growth hormone protocols built around pre-bed timing were designed for bodies that do not make their own growth hormone, and applied wholesale to people who still have a functioning pituitary, that timing smothers a pulse your body was already generating for free while missing the insulin overlap window your liver actually needs to do the conversion. The protocol was not wrong for the population it was tested on. It was just never meant for yours.

---

References

1. Van Cauter E, Plat L. (1996). Physiology of growth hormone secretion during sleep. J Pediatr 128(5 Pt 2):S32-37. DOI: 10.1016/s0022-3476(96)70008-2
2. Jorgensen JO, Moller N, Moller J, Weeke J, Christiansen JS. (1985). Pharmacokinetics of biosynthetic authentic human growth hormone in normal men after subcutaneous or intramuscular injection. Acta Endocrinol (Copenh). PMID: 4034296
3. Jorgensen JO, Moller N, Lauritzen T, Alberti KG, Orskov H, Christiansen JS. (1990). Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab 70(1):207-14. PMID: 2294131. DOI: 10.1210/jcem-70-1-207
4. Moller N, Jorgensen JO. (2009). Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30(2):152-77. PMID: 19240267. DOI: 10.1210/er.2008-0027
5. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli GB. (1990). Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia 33(1):52-9. PMID: 2406181. DOI: 10.1007/BF00586461

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness